Dexcom (DXCM) Net Income towards Common Stockholders (2010 - 2026)
Dexcom's Net Income towards Common Stockholders came in at $249.1 million for Q2 2026, up 38.5% from $179.8 million a year earlier and up 24.9% from the prior quarter.
Powered by 
Analysis
Dexcom (DXCM) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dexcom reported Net Income towards Common Stockholders of $999.7 million, up 74.9% year-over-year; for FY2025, it was $836.3 million, up 45.1% from FY2024.
- Net Income towards Common Stockholders has increased in each of the last four years, with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- Going back by year, Net Income towards Common Stockholders was $576.2 million in FY2024 (+6.4%), $541.5 million in FY2023 (+58.7%), $341.2 million in FY2022 (+57.3%) and $216.9 million in FY2021 (-60.5%).
- The five-year range for quarterly Net Income towards Common Stockholders is -$5.3 million (Q4 2021) to $283.8 million (Q3 2025).
- Year-over-year, Net Income towards Common Stockholders has increased for five consecutive quarters, with growth averaging 35.4% over the last eight quarters.
- The fastest year-over-year change in Net Income towards Common Stockholders over five years came in Q1 2024 (growth of 201.2%), and the weakest in Q1 2023 (a decline of 50.1%).
- Business Quant data shows DXCM's Net Income towards Common Stockholders at $199.5 million (Q1 2026), $267.3 million (Q4 2025) and $283.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 818.10 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 241.90 Mn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 377.00 Mn |
| 10 | Dexcom | 32.21 Bn | 22.53 Bn | 830.00 Mn | 249.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.10 Mn |
| Mar 31, 2026 | 199.50 Mn |
| Dec 31, 2025 | 267.30 Mn |
| Sep 30, 2025 | 283.80 Mn |
| Jun 30, 2025 | 179.80 Mn |
| Mar 31, 2025 | 105.40 Mn |
| Dec 31, 2024 | 151.70 Mn |
| Sep 30, 2024 | 134.60 Mn |
| Jun 30, 2024 | 143.50 Mn |
| Mar 31, 2024 | 146.40 Mn |
| Dec 31, 2023 | 256.30 Mn |
| Sep 30, 2023 | 120.70 Mn |
| Jun 30, 2023 | 115.90 Mn |
| Mar 31, 2023 | 48.60 Mn |
| Dec 31, 2022 | 91.80 Mn |
| Sep 30, 2022 | 101.20 Mn |
| Jun 30, 2022 | 50.90 Mn |
| Mar 31, 2022 | 97.30 Mn |
| Dec 31, 2021 | -5.30 Mn |
| Sep 30, 2021 | 87.30 Mn |
API Access
Dexcom Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DXCM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();